Maven Securities’s BioTelemetry, Inc. BEAT Stock Holding History

Maven Securities’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-94,348	Closed	-$6.8M	–	1415
2020 Q4	$6.8M	Buy	+94,348	New	+$4.94M	0.67%	34

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Maven Securities's BEAT Position: Q1 2021 in Review

Maven Securities sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 94,348 shares — an estimated $6.8M sold.

Maven Securities first reported a position in BEAT in Q4 2020 and held it in 1 quarter. The position peaked at $6.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Maven Securities reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Maven Securities sold 94,348 BioTelemetry, Inc. shares in Q1 2021, an estimated $6.8M.
Maven Securities first reported a position in BioTelemetry, Inc. in Q4 2020 and held it in 1 quarter.
Maven Securities's BioTelemetry, Inc. position peaked at $6.8M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.